BACK
IMAC Holdings Inc
Q1 2025 Report
IMAC Holdings Inc (BACK) Q1 2025 Results - A Challenging Quarter with Strategic Focus on Recovery...
Read full report
Executive Summary
In Q2 2024, IMAC Holdings Inc (BACK) reported significant financial challenges, characterized by a steep decline in revenue and substantial net losses. Revenue reached only $15,750, representing a staggering 98.83% year-over-year decrease. The company incurred a gross loss of $56,252, largely attributed to high operational expenses totaling $1,416,694. While management continues to emphasize leveraging its outpatient medical clinics for sports injuries and related services, the persistent operational losses indicate a critical juncture for the company's strategy in the competitive healthcare environment. Management expressed a commitment to refining cost control measures, albeit amidst declining patient volumes and market headwinds that necessitate a reevaluation of growth strategies.
Key Performance Indicators
Revenue
15.75K
QoQ: N/A | YoY:-98.83%
Gross Profit
-56.25K
-3.57% margin
QoQ: 62.55% | YoY:-104.82%
Operating Income
-1.40M
QoQ: -243.08% | YoY:-1.52%
Net Income
-1.38M
QoQ: -239.72% | YoY:1.42%
EPS
-1.17
QoQ: -234.29% | YoY:7.87%
Revenue Trend
Margin Analysis
Key Insights
**Financial Performance:** Revenue for Q2 2024 was $15,750, down from $1,347,975 a year prior. This decline translated into a gross profit margin of -3.57%, underscoring severe profitability challenges. Year-over-year decreases in key metrics were notable: gross profit dropped by over 104%, and operating income remains negative at -$1,401,944, reflecting an operating income ratio of -89.01%. Furthermore, the net income totaled -$1,383,404, equating to an EPS of -1.17. **Liquidity and Cash Flow:...